tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZLAB Stock Latest News

Zai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer
Company AnnouncementsZai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer
2d ago
ZLAB
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
PremiumRatings
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
5d ago
ZLAB
Zai Lab Earnings Call: Growth, Pipeline And Volatility
PremiumCompany Announcements
Zai Lab Earnings Call: Growth, Pipeline And Volatility
11d ago
ZLAB
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
PremiumThe Fly
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
16d ago
ZLAB
Zai Lab price target lowered to $47 from $53 at Citi
PremiumThe Fly
Zai Lab price target lowered to $47 from $53 at Citi
16d ago
ZLAB
Zai Lab reports Q4 EPS (46c), consensus (42c)
PremiumThe FlyZai Lab reports Q4 EPS (46c), consensus (42c)
17d ago
ZLAB
Zai Lab price target lowered to $53 from $58 at Citi
Premium
The Fly
Zai Lab price target lowered to $53 from $58 at Citi
23d ago
ZLAB
Zai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
Premium
Company Announcements
Zai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
1M ago
ZLAB
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
PremiumCompany Announcements
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
1M ago
ZLAB
Zai Lab price target lowered to $39 from $46 at JPMorgan
PremiumThe Fly
Zai Lab price target lowered to $39 from $46 at JPMorgan
1M ago
ZLAB
Zai Lab initiated with a Buy at UBS
PremiumThe Fly
Zai Lab initiated with a Buy at UBS
2M ago
ZLAB
Zai Lab announces China NMPA approval for Augtryo sNDA
PremiumThe Fly
Zai Lab announces China NMPA approval for Augtryo sNDA
2M ago
ZLAB
Zai Lab rises 7.4%
PremiumThe FlyZai Lab rises 7.4%
3M ago
ZLAB
Morning Movers: Novo Nordisk gains after Wegovy pill approved
Premium
The Fly
Morning Movers: Novo Nordisk gains after Wegovy pill approved
3M ago
HII
JNJ
Zai Lab announces China NMPA approval for Cobenfy
Premium
The Fly
Zai Lab announces China NMPA approval for Cobenfy
3M ago
ZLAB
Zai Lab doses first patient in ZL-1503 trial
PremiumThe Fly
Zai Lab doses first patient in ZL-1503 trial
3M ago
ZLAB
Zai Lab announces updates to China’s National Reimbursement Drug List
PremiumThe Fly
Zai Lab announces updates to China’s National Reimbursement Drug List
3M ago
ZLAB
Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges
PremiumCompany Announcements
Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges
4M ago
ZLAB
Zai Lab Reports Strong Q3 2025 Growth and Pipeline Progress
PremiumCompany Announcements
Zai Lab Reports Strong Q3 2025 Growth and Pipeline Progress
4M ago
ZLAB
Zai Lab reports Q3 EPS (3c), consensus (29c)
PremiumThe FlyZai Lab reports Q3 EPS (3c), consensus (29c)
4M ago
ZLAB
Zai Lab sees FY25 revenue at least $460M, consensus $556.41M
Premium
The Fly
Zai Lab sees FY25 revenue at least $460M, consensus $556.41M
4M ago
ZLAB
Zai Lab removed from APAC Conviction List at Goldman Sachs
Premium
The Fly
Zai Lab removed from APAC Conviction List at Goldman Sachs
4M ago
ZLAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >